Combination of cardioprotective glucose-lowering drugs and statins on cardiovascular mortality in diabetes: a nationwide cohort study
In individuals with type 2 diabetes, treatment with a combination of cardioprotective glucose-lowering drug and statin was associated with a lower risk of cardiovascular mortality than using either drug alone.
Authors
- Tummas Ternhamar (ORCID: https://orcid.org/0000-0001-8896-0724)
- Mia Ø Johansen (ORCID: https://orcid.org/0000-0001-8161-9152)
- Shoaib Afzal
- Børge G Nordestgaard
Institutions
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1093/eurjpc/zwag085
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00